BioMed Research International / 2018 / Article / Fig 2

Review Article

A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma

Figure 2

(a) Immunohistochemistry evaluation of TGF-β3 expression in patient matched myometrium (M) and leiomyoma (L) representative specimen. (b) Quantitation of TGF-β3 immunostaining revealing a decrease in TGF-β3 expression in treated leiomyoma, as compared to placebo.
(a)
(b)